Management of Patients with Alzheimer’s Disease plus Cerebrovascular Disease: 12-Month Treatment with Galantamine
Year: 2003
Type: article
DOI: 10.1159/000074140
Institution: Helsinki University Hospital
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, cerebrovascular disease, mixed dementia, galantamine, long-term cognitive outcomes, cognitive function, treatment safety, Alzheimer's Disease Assessment Scale, cholinesterase inhibitors, open-label extension, cognitive decline prevention, adverse events, vascular dementia, dementia with Lewy bodies, multiple system atrophy, multiple sclerosis
Open Access status: closed
OpenAlex ID: W2040088037
